Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

High-Flow Nasal Cannula Versus Standard Oxygen Therapy After Extubation in Liver Transplantation: A Matched Controlled Study.

Gaspari R, Spinazzola G, Ferrone G, Soave PM, Pintaudi G, Cutuli SL, Avolio AW, Conti G, Antonelli M.

Respir Care. 2019 Jul 3. pii: respcare.06866. doi: 10.4187/respcare.06866. [Epub ahead of print]

PMID:
31270177
2.

Charting the Path Forward for Risk Prediction in Liver Transplant for HCC: International Validation of HALTHCC amongst 4,089 patients.

Firl DJ, Sasaki K, Agopian VG, Gorgen A, Kimura S, Dumronggittigule W, McVey JC, Iesari S, Mennini G, Vitale A, Finkenstedt A, Onali S, Hoppe-Lotichius M, Vennarecci G, Manzia TM, Nicolini D, Avolio AW, Agnes S, Vivarelli M, Tisone G, Ettorre GM, Otto G, Tsochatzis E, Rossi M, Viveiros A, Cillo U, Markmann JF, Ikegami T, Kaido T, Lai Q, Sapisochin G, Lerut J; European Hepatocellular Cancer Liver Transplant Study Group, Aucejo FN.

Hepatology. 2019 Jun 27. doi: 10.1002/hep.30838. [Epub ahead of print]

PMID:
31243778
3.

The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation.

Lai Q, Vitale A, Iesari S, Finkenstedt A, Mennini G, Onali S, Hoppe-Lotichius M, Manzia TM, Nicolini D, Avolio AW, Mrzljak A, Kocman B, Agnes S, Vivarelli M, Tisone G, Otto G, Tsochatzis E, Rossi M, Viveiros A, Ciccarelli O, Cillo U, Lerut J; European Hepatocellular Cancer Liver Transplant Study Group.

Liver Transpl. 2019 Jul;25(7):1023-1033. doi: 10.1002/lt.25492.

PMID:
31087772
4.

Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis.

Avolio AW, Gaspari R, Teofili L, Bianco G, Spinazzola G, Soave PM, Paiano G, Francesconi AG, Arcangeli A, Nicolotti N, Antonelli M.

PLoS One. 2019 Feb 11;14(2):e0211678. doi: 10.1371/journal.pone.0211678. eCollection 2019.

5.

Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma.

Ponziani FR, Spinelli I, Rinninella E, Cerrito L, Saviano A, Avolio AW, Basso M, Miele L, Riccardi L, Zocco MA, Annicchiarico BE, Garcovich M, Biolato M, Marrone G, De Gaetano AM, Iezzi R, Giuliante F, Vecchio FM, Agnes S, Addolorato G, Siciliano M, Rapaccini GL, Grieco A, Gasbarrini A, Pompili M.

World J Hepatol. 2017 Dec 28;9(36):1322-1331. doi: 10.4254/wjh.v9.i36.1322.

6.

Obesity as predictor of postoperative outcomes in liver transplant candidates: Review of the literature and future perspectives.

Barone M, Viggiani MT, Avolio AW, Iannone A, Rendina M, Di Leo A.

Dig Liver Dis. 2017 Sep;49(9):957-966. doi: 10.1016/j.dld.2017.07.004. Epub 2017 Jul 22. Review.

PMID:
28801180
7.

Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.

Lai Q, Vitale A, Iesari S, Finkenstedt A, Mennini G, Spoletini G, Hoppe-Lotichius M, Vennarecci G, Manzia TM, Nicolini D, Avolio AW, Frigo AC, Graziadei I, Rossi M, Tsochatzis E, Otto G, Ettorre GM, Tisone G, Vivarelli M, Agnes S, Cillo U, Lerut J; European Hepatocellular Cancer Liver Transplant Study Group.

Hepatology. 2017 Dec;66(6):1910-1919. doi: 10.1002/hep.29342. Epub 2017 Nov 6.

PMID:
28653750
8.

Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review.

Frongillo F, Bianco G, Silvestrini N, Lirosi MC, Sanchez AM, Nure E, Gaspari R, Avolio AW, Sganga G, Agnes S.

Transplant Proc. 2015 Sep;47(7):2179-81. doi: 10.1016/j.transproceed.2014.11.072. Review.

PMID:
26361673
9.

Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation.

Frongillo F, Lirosi MC, Nure E, Inchingolo R, Bianco G, Silvestrini N, Avolio AW, De Gaetano AM, Cina A, Di Stasi C, Sganga G, Agnes S.

Transplant Proc. 2015 Sep;47(7):2150-5. doi: 10.1016/j.transproceed.2014.11.068.

PMID:
26361665
10.

Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection.

Barone M, Notarnicola A, Lopalco G, Viggiani MT, Sebastiani F, Covelli M, Iannone F, Avolio AW, Di Leo A, Cantarini L, Lapadula G.

Hepatology. 2015 Jul;62(1):40-6. doi: 10.1002/hep.27716. Epub 2015 Feb 24.

PMID:
25613809
11.

Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation.

Frongillo F, Lirosi MC, Sganga G, Grossi U, Nure E, Avolio AW, Bianco G, Mariano G, Agnes S.

Transplant Proc. 2014 Sep;46(7):2293-4. doi: 10.1016/j.transproceed.2014.07.057.

PMID:
25242772
12.

Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up.

Ponziani FR, Zocco MA, Senzolo M, Pompili M, Gasbarrini A, Avolio AW.

Transplant Rev (Orlando). 2014 Apr;28(2):92-101. doi: 10.1016/j.trre.2014.01.003. Epub 2014 Jan 27. Review.

PMID:
24582320
13.

Response to locoregional treatment and alpha-fetoprotein trend in liver transplant candidates for HCC: dwarfs standing on the shoulders of giants.

Lai Q, Avolio AW, Graziadei I, Lerut J; European Hepatocellular Cancer Liver Transplant (EurHeCaLT) Study Group.

J Hepatol. 2014 Jun;60(6):1331-2. doi: 10.1016/j.jhep.2014.01.030. Epub 2014 Feb 19. No abstract available.

14.

Prediction of poor graft function by means of gastric tonometry in patients undergoing liver transplantation.

Perilli V, Aceto P, Modesti C, Vitale F, Ciocchetti P, Sacco T, Adduci A, Lai C, Avolio AW, Sollazzi L.

Ann Hepatol. 2013 Jan-2014 Feb;13(1):54-9.

15.

Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.

Pompili M, Francica G, Ponziani FR, Iezzi R, Avolio AW.

World J Gastroenterol. 2013 Nov 21;19(43):7515-30. doi: 10.3748/wjg.v19.i43.7515. Review.

16.

Can we match donors and recipients in a cost-effective way?

Avolio AW, Burra P.

Transpl Int. 2013 Nov;26(11):1061-2. doi: 10.1111/tri.12189. No abstract available.

17.

Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center.

Nure E, Frongillo F, Lirosi MC, Grossi U, Sganga G, Avolio AW, Siciliano M, Addolorato G, Mariano G, Agnes S.

Transplant Proc. 2013 Sep;45(7):2733-5. doi: 10.1016/j.transproceed.2013.08.011.

PMID:
24034035
18.

Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match.

Frongillo F, Grossi U, Lirosi MC, Nure E, Sganga G, Avolio AW, Inchingolo R, Di Stasi C, Rinaldi P, Agnes S.

Transplant Proc. 2013 Sep;45(7):2722-5. doi: 10.1016/j.transproceed.2013.08.007.

PMID:
24034032
19.

Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation.

Lai Q, Avolio AW, Graziadei I, Otto G, Rossi M, Tisone G, Goffette P, Vogel W, Pitton MB, Lerut J; European Hepatocellular Cancer Liver Transplant Study Group.

Liver Transpl. 2013 Oct;19(10):1108-18. doi: 10.1002/lt.23706.

20.

D-MELD, a strong and accurate tool to guide donor-2-recipient matching.

Avolio AW, Halldorson JB, Lirosi MC, Lupo L, Nicolotti N, Agnes S.

Ann Transplant. 2013 Apr 8;18:161-2. doi: 10.12659/AOT.883876. No abstract available.

PMID:
23792516
21.

Balancing utility and need by means of donor-to-recipient matching: a challenging problem.

Avolio AW, Halldorson JB, Burra P, Dutkowski P, Agnes S, Clavien PA.

Am J Transplant. 2013 Feb;13(2):522-3. doi: 10.1111/ajt.12031. Epub 2013 Jan 2. No abstract available.

22.

Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.

Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN; Liver Match Investigators.

J Hepatol. 2013 Apr;58(4):715-23. doi: 10.1016/j.jhep.2012.11.025. Epub 2012 Nov 28.

PMID:
23201239
23.

Low values of left ventricular ejection time in the post-anhepatic phase may be associated with occurrence of primary graft dysfunction after orthotopic liver transplantation: results of a single-centre case-control study.

Perilli V, Aceto P, Modesti C, Ciocchetti P, Sacco T, Vitale F, Lai C, Magalini SC, Avolio AW, Sollazzi L.

Eur Rev Med Pharmacol Sci. 2012 Oct;16(10):1433-40.

24.

Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation.

Frongillo F, Grossi U, Avolio AW, Sganga G, Nure E, Pepe G, Bianco G, Lirosi MC, Agnes S.

Transplant Proc. 2012 Sep;44(7):2002-4. doi: 10.1016/j.transproceed.2012.06.008.

PMID:
22974892
25.

Model for end-stage liver disease dynamic stratification of survival benefit.

Avolio AW, Siciliano M, Barone M, Lai Q, Caracciolo GL, Barbarino R, Nicolotti N, Lirosi MC, Gasbarrini A, Agnes S.

Transplant Proc. 2012 Sep;44(7):1851-6. doi: 10.1016/j.transproceed.2012.06.056.

PMID:
22974854
26.

Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West.

Lai Q, Avolio AW, Lerut J, Singh G, Chan SC, Berloco PB, Tisone G, Agnes S, Chok KS, Sharr W, Rossi M, Manzia TM, Lo CM.

J Hepatol. 2012 Nov;57(5):974-9. doi: 10.1016/j.jhep.2012.06.033. Epub 2012 Jul 6.

PMID:
22771712
27.

http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation.

Avolio AW, Agnes S, Cillo U, Lirosi MC, Romagnoli R, Baccarani U, Zamboni F, Nicolini D, Donataccio M, Perrella A, Ettorre GM, Romano M, Morelli N, Vennarecci G, de Waure C, Fagiuoli S, Burra P, Cucchetti A.

Transpl Int. 2012 Mar;25(3):294-301. doi: 10.1111/j.1432-2277.2011.01423.x. Epub 2012 Jan 23.

28.

Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation.

Lai Q, Avolio AW, Manzia TM, Sorge R, Agnes S, Tisone G, Berloco PB, Rossi M.

Clin Transplant. 2012 Mar-Apr;26(2):E125-31. doi: 10.1111/j.1399-0012.2011.01572.x. Epub 2011 Dec 22.

PMID:
22192083
29.

Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it?

Lai Q, Avolio AW, Manzia TM, Agnes S, Tisone G, Berloco PB, Rossi M.

Int J Biol Markers. 2011 Jul-Sep;26(3):153-9. doi: 10.5301/JBM.2011.8557. Epub 2011 Jul 25.

PMID:
21928243
30.

Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients.

Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, Tisone G, Romagnoli R, Caccamo L, Rossi M, Vitale A, Cucchetti A, Lupo L, Gruttadauria S, Nicolotti N, Burra P, Gasbarrini A, Agnes S; Donor-to-Recipient Italian Liver Transplant (D2R-ILTx) Study Group.

Am J Transplant. 2011 Dec;11(12):2724-36. doi: 10.1111/j.1600-6143.2011.03732.x. Epub 2011 Sep 15.

31.

Comment to "Liver Match: a prospective observational cohort study on liver transplantation in Italy".

Avolio AW, Gruttadauria S, Grieco A, De Feo TM.

Dig Liver Dis. 2011 Nov;43(11):921; author reply 921-2. doi: 10.1016/j.dld.2011.05.016. Epub 2011 Jul 14. No abstract available.

PMID:
21752740
32.

Psychological risk factors for graft rejection among liver transplant recipients.

Calia R, Lai C, Aceto P, Luciani M, Saraceni C, Avolio AW, Agnes S.

Transplant Proc. 2011 May;43(4):1123-7. doi: 10.1016/j.transproceed.2011.01.159.

PMID:
21620068
33.

Late development of splenic artery aneurysm after orthotopic liver transplantation: a case report.

Annicchiarico BE, Avolio AW, Caracciolo G, Barbaro B, Di Stasi C, Agnes S, Siciliano M.

Transplant Proc. 2009 May;41(4):1383-5. doi: 10.1016/j.transproceed.2009.03.025.

PMID:
19460566
34.

Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report.

Annicchiarico BE, Siciliano M, Avolio AW, Agnes S, Bombardieri G.

Transplant Proc. 2009 May;41(4):1380-2. doi: 10.1016/j.transproceed.2009.03.023.

PMID:
19460565
35.

Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients.

Nure E, Magalini SC, Frongillo F, Barbarino R, Pepe G, Avolio AW, Agnes S.

Transplant Proc. 2009 May;41(4):1290-2. doi: 10.1016/j.transproceed.2009.03.041.

PMID:
19460541
36.

Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival.

Frongillo F, Avolio AW, Nure E, Mulè A, Pepe G, Magalini SC, Agnes S.

Transplant Proc. 2009 May;41(4):1268-72. doi: 10.1016/j.transproceed.2009.03.096.

PMID:
19460535
37.

Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.

Gaspari R, Cavaliere F, Sollazzi L, Perilli V, Melchionda I, Agnes S, Gasbarrini A, Avolio AW.

Transplant Proc. 2009 Jan-Feb;41(1):253-8. doi: 10.1016/j.transproceed.2008.10.066.

PMID:
19249528
38.

Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.

Avolio AW, Frongillo F, Nicolotti N, Mulè A, Vennarecci G, De Simone P, Agnes S.

Transplant Proc. 2009 Jan-Feb;41(1):208-12. doi: 10.1016/j.transproceed.2008.10.050.

PMID:
19249515
39.

Use of an esophageal echo-Doppler device during liver transplantation: preliminary report.

Perilli V, Avolio AW, Sacco T, Modesti C, Gaspari R, Caserta R, Agnes S, Sollazzi L.

Transplant Proc. 2009 Jan-Feb;41(1):198-200. doi: 10.1016/j.transproceed.2008.09.054.

PMID:
19249513
40.

Donor-recipient MELD-based match in a patient who required three liver grafts in the era of nonstandard donors: case report.

Avolio AW, Barbarino R, Siciliano M, Annicchiarico BE, Frongillo F, Agnes S, Castagneto M.

Transplant Proc. 2008 Jul-Aug;40(6):2067-9. doi: 10.1016/j.transproceed.2008.06.004.

PMID:
18675132
41.

Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches.

Avolio AW, Nure E, Pompili M, Barbarino R, Basso M, Caccamo L, Magalini S, Agnes S, Castagneto M.

Transplant Proc. 2008 Jul-Aug;40(6):1961-4. doi: 10.1016/j.transproceed.2008.05.071.

PMID:
18675101
42.

Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation.

Annicchiarico BE, Avolio AW, Siciliano M, Passalacqua S, Caracciolo G, Gasbarrini A, Agnes S, Castagneto M.

Transplant Proc. 2008 Jul-Aug;40(6):1929-31. doi: 10.1016/j.transproceed.2008.05.064.

PMID:
18675092
43.

Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation.

Annicchiarico BE, Siciliano M, Avolio AW, Caracciolo G, Gasbarrini A, Agnes S, Castagneto M.

Transplant Proc. 2008 Jul-Aug;40(6):1918-20. doi: 10.1016/j.transproceed.2008.06.002.

PMID:
18675089
44.

Donor risk index and organ patient index as predictors of graft survival after liver transplantation.

Avolio AW, Siciliano M, Barbarino R, Nure E, Annicchiarico BE, Gasbarrini A, Agnes S, Castagneto M.

Transplant Proc. 2008 Jul-Aug;40(6):1899-902. doi: 10.1016/j.transproceed.2008.05.070.

PMID:
18675083
45.

ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption.

Barone M, Avolio AW, Di Leo A, Burra P, Francavilla A.

Transplantation. 2008 Mar 27;85(6):844-9. doi: 10.1097/TP.0b013e318166cc38.

PMID:
18360266
46.

Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series.

Avolio AW, Agnes S, Barbarino R, Magalini SC, Frongillo F, Pagano L, Larocca LM, Pompili M, Caira M, Sollazzi L, Castagneto M.

Transplant Proc. 2007 Jul-Aug;39(6):1956-60.

PMID:
17692665
47.

A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy.

Annicchiarico BE, Siciliano M, Avolio AW, Grillo RL, Bombardieri G.

Aliment Pharmacol Ther. 2007 May 1;25(9):1039-46.

48.

Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued?

Avolio AW, Agnes S, Gasbarrini A, Barbarino R, Nure E, Siciliano M, Barone M, Castagneto M.

Transplant Proc. 2006 Dec;38(10):3567-71.

PMID:
17175333
49.

Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.

Gaspari R, Avolio AW, Zileri Dal Verme L, Agnes S, Proietti R, Castagneto M, Gasbarrini A.

Transplant Proc. 2006 Dec;38(10):3544-51.

PMID:
17175327
50.

Comparative evaluation of two perfusion solutions for liver preservation and transplantation.

Avolio AW, Agnes S, Nure E, Maria G, Barbarino R, Pepe G, Castagneto M.

Transplant Proc. 2006 May;38(4):1066-7.

PMID:
16757265

Supplemental Content

Loading ...
Support Center